FDA delays decision on first drug to prevent HIV infection
London: US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.
Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.
In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.
The group’s vote is non-binding, but the FDA often follows its advice.
Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.
The FDA typically extends its reviews after receiving such information.
More from India
More from World
More from Sports
More from Entertaiment
- Security guard beats woman journalist publicly in Pakistan
- Pakistan violates ceasefire in J&K's Hiranagar; 7 Pak Rangers killed, BSF jawan injured
- ISIS terrorists escape Mosul disguised in women's clothing
- DNA: Pakistan violates ceasefire in J&K's Hiranagar; Seven Pak Rangers killed
- DNA: Analysing the existing poor condition of Indian education system
- MS Dhoni reacts in astonishment as Axar Patel takes a stunning one-handed catch - VIDEO
- BSP shrugs off Rita Bahuguna 's jump; says BJP will still face defeat in UP polls
- Navjot Singh Sidhu out on zero to Waqar Younis in 1990 – The match Kapil Sharma keeps talking about
- MS Dhoni or Virat Kohli? Here's Virender Sehwag's best ever reply
- Sushant Singh Rajput’s former girlfriend Ankita Lokhande’s Karva Chauth photos will surprise you